The Bleeding Edge of Decision Making in Managed Health Care—Kaiser-Permanente's Model for Formulary Development
FDA Actions against Misleading or Unsubstantiated Economic and Quality-of-Life Promotional Claims
Bootstrap Confidence Intervals for Costs-of-Illness of Type 2 Diabetes Mellitus in Germany
The Cost-Effectiveness of Alternative Therapeutic Strategies for the Management of Chronic Hepatitis B in Poland
Validation of the Patient Perception of Migraine Questionnaire
Odds Ratio, Relative Risk, Absolute Risk Reduction, and the Number Needed to Treat—Which of These Should We Use?
Comparative Analysis of Two Quality-of-Life Instruments for Patients with Chronic Obstructive Pulmonary Disease